BioCentury
ARTICLE | Company News

Management tracks

April 29, 2015 12:28 AM UTC

Biosimilar play Pfenex Inc. (NYSE-M:PFNX) elected John Taylor to its board of directors. Taylor, a principal at Greenleaf Health LLC, was counselor to the FDA commissioner until January 2014.

Autoimmune play TxCell S.A. (Euronext:TXCL) named Stephane Boissel CEO and promoted Miguel Forte to COO. Boissel was CEO of Genclis S.A.S. (Vandoeuvre les Nancy, France); he replaces Damian Marron, who resigned. Forte was TxCell's SVP of clinical and regulatory. ...